ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. The company is headquartered in Rancho Cordova, California and currently employs 25 full-time employees. The firm provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, the PXP platform for point-of-care cell-based therapies and X-Series products for cell processing services. Its product lines include Clinical Bio-Banking Applications, Point-of-Care Applications and Cell Processing. Its Clinical Bio-Banking Applications include AXP II Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, and PXP-1000 System. Its Cell Processing includes X-Series Products for general laboratory use: X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The firm markets and sells its medical device products through independent distributors.
Follow-Up Questions
Thermogenesis Holdings Inc (THMO) 的市盈率是多少?
Thermogenesis Holdings Inc 的市盈率是 0
Thermogenesis Holdings Inc 的 CEO 是谁?
Dr. Xiaochun Xu 是 Thermogenesis Holdings Inc 的 Chairman of the Board,自 2016 加入公司。
THMO 股票的价格表现如何?
THMO 的当前价格为 $0.0001,在上个交易日 decreased 了 0%。
Thermogenesis Holdings Inc 的主要业务主题或行业是什么?
Thermogenesis Holdings Inc 属于 Health Care 行业,该板块是 Health Care